Natriumchlorid 0,9 % (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchlorid 0,9 %, is an electrolyte solution presented as a 0.9% w/v solution for injection for intravenous use. It restores sodium and chloride balance and is used in fluid replacement and electrolyte replenishment in patients requiring intravenous therapy.

GNH USA supplies Natriumchlorid 0,9 % as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Natriumchlorid 0,9 % is an isotonic electrolyte solution used in the management of fluid and electrolyte disorders.

- Fluid replacement: provides isotonic fluid to restore intravascular volume in patients with fluid loss. - Electrolyte replenishment: restores sodium and chloride concentrations in the extracellular compartment. - Treatment of dehydration: supplies necessary water and electrolytes to re‑hydrate dehydrated individuals. - Management of hypovolemia: supports circulatory volume in trauma or surgical patients. - Vehicle for intravenous drug administration: serves as a compatible carrier for diluted injectable medicines.

Adverse reactions may occur with any intravenous solution. Most are mild and related to the infusion process.

Common Side Effects: - Pain or irritation at the injection site. - Phlebitis or superficial vein inflammation. - Mild hypernatremia or hyperchloremia. - Transient edema at the infusion site. - Slight increase in blood pressure.

Serious or Rare Side Effects: - Volume overload leading to pulmonary edema. - Severe hypernatremia causing neurological symptoms. - Metabolic acidosis from excessive chloride load. - Anaphylactoid reactions (rare). - Electrolyte imbalance precipitating cardiac arrhythmias.

Before administering Natriumchlorid 0,9 %, clinicians should evaluate patient‑specific factors and monitor therapy.

- Assess volume status: ensure the patient is not already fluid overloaded. - Monitor electrolytes: check serum sodium and chloride levels during treatment. - Evaluate renal function: adjust use in patients with impaired kidney clearance. - Review cardiac status: be cautious in heart‑failure or hypertension. - Store at ambient temperature: keep in original packaging, protect from light and moisture.

Sodium chloride solution can interact with other agents that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Hypertonic saline solutions: concurrent use may cause severe hypernatremia. - Potassium chloride admixtures: may lead to hyperchloremic metabolic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte shifts; monitor serum levels. - ACE inhibitors or ARBs: potential for altered potassium balance when combined with potassium‑containing fluids. - Cardiac glycosides: electrolyte disturbances can affect drug toxicity; observe cardiac function.